2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Racial Differences Amongst Infants Undergoing Intestine Transplants.

K. Khan, C. Desai, S. Kaufman, R. Girlanda, J. Hawksworth, A. Kroemer, T. Fishbein, C. Matsumoto.
Racial Disparities in Cognitive and Social Requirements Prior to Listing for Liver Transplant.

M. Jesse, E. Goldstein, T. Macaulay, N. Rebhan, C.-X. Ho, M. Bebanic, L. Shkokani, M. Abouljoud, A. Eshelman, A. Yoshida.
Racial Disparities in Perioperative Complications After Live Kidney Donation.

K. Lentine,¹ N. Lam,² D. Axelrod,³ M. Schnitzler,¹ A. Garg,⁴ J. Schold,⁵ D. Brennan,⁶ H. Randall,¹ D. Segev.⁷
Racial Disparities in the Evaluation for Liver Transplantation.

M. Jesse, E. Goldstein, N. Rebhan, C.-X. Ho, T. Macaulay, M. Bebanic, L. Shkokani, D. Moonka, M. Abouljoud, A. Yoshida.
Radiosensitive Cell Population Prolongs Graft Survival of Vascularized Composite Allografts in Non-Human Primates.

M. Uluer, J. Woodall, W. Hassanein, U. Drhu, B. Bojovic, A. Nam, S. Bartlett, R. Barth.
Randomized Controlled Study Evaluating Adherence Monitoring with Electronic Feedback on Reducing Renal Allograft Rejection.

A. Bodzin, Y. Becker, M. Josephson, P. Witkowski, M. Lockwood, L. Potter, B. Kane, L. Lourenco, J. Millis.
Randomized Controlled Trial of Mixed Acute Rejection Therapy in Renal Allografts: 3 Year Follow Up.

A. Leino,¹ A. Lichvar,¹ B. Abu-Jawdeh,¹ A. Govil,¹ G. Mogilishetty,¹ M. Cardi,² J. Kremer,² M. Cuffy,¹ F. Paterno,¹ R. Alloway,¹ A. Shields,^1,2 E. Woodle.¹
Rapamycin (RPM) Synergizes with CD154 mAb and DST to Promote Long-Term Vascularized Composite Allograft (VCA) Survival, but Prevents Induction of Donor-Specific Tolerance.

L. Wang, Z. Wang, R. Han, T. Bhatti, L. Levin, M. Levine, W. Hancock.
Rapamycin Encapsulated Nanoparticles as Pre-Treatment in Lung Transplantation.

G. Bazzle,¹ S. Dixit,² K. Patel,³ A.-M. Broome,² S. Nadig,^1,3 C. Atkinson.^1,3
Rapamycin Nanotherapy Delays Heart Transplant Rejection.

M. Braza,¹ M. Lameijer,¹ C. Perez-Medina,¹ T. Reiner,³ M. Nahrendorf,⁴ Z. Fayad,¹ R. Duivenvoorden,¹ J. Ochando,² W. Mulder.¹
Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.

T. Nakamura, K. Masuda, T. Matsuyama, H. Ushigome, N. Yoshimura.
Rapid Detection of Acute Infection in Immunosuppressed Renal Patients with IRIDICA: A Pilot Study.

S. Hassan,¹ A. Adwaney,¹ A. Massiah,² R. Murphy,² S. Law,¹ S. Mohd-Afzal,¹ M. Wilks,² R. Thuraisingham.¹
Rapid Detection of Urinary CXCL9 as a Diagnostic and Prognostic Tool for Managing Acute Cellular Rejection (ACR) in Kidney Transplantation.

I. Gandolfini,¹ C. Harris,¹ C. Purroy,¹ V. Nair,¹ J. Reid-Adam,¹ O. Bestard,² P. Heeger.¹
Rapid Discontinuation of Prednisone (RDP) in Kidney Transplant (KTx) Recipients: 15-Year Outcomes.

O. Serrano,¹ R. Kandaswamy,¹ K. Gillingham,¹ W. Payne,¹ T. Dunn,¹ S. Chinnakotla,¹ E. Finger,¹ H. Ibrahim,² A. Kukla,² R. Spong,² N. Issa,² T. Pruett,¹ A. Matas.¹
Rapid Emergence of CD28^null Cells Following Ex Vivo Restimulation Is Associated with Belatacept Resistant Rejection.

M. Cortes, S. Laurie, B. Sayed, M. Ford.
Rapid Withdrawal of Donation After Cardiac Death Donors.

K. Mekeel,¹ J. Trageser,² W. Garrison,² J. Berumen,¹ L. Stocks,² A. Hemming.¹
Rare Presentation of PTLD as Parotitis.

R. Pullalarevu, A. Posadas Salas, G. Mour, T. Srinivas, N. Salazar, P. Mohan.
Re-Examining the Role of B-1 Cells in a Murine Model of Renal Ischemia Reperfusion Injury.

D. Firl,^1,2,3 A. Das,¹ J. Fung,² M. Carroll.¹
Real Time Assessment of Kidney Transplant Indication Biopsies by Microarrays: First Results of the INTERCOMEX Study.

P. Halloran,^1,2 J. Reeve,¹ INTERCOMEX Study Group.
Really Old (>84 Years) Deceased Donor Livers Can Save Lives.

A. Friedman, E. Marquez, K. DelliCarpini.
Recall Alloantibody Production Is Driven by CD138⁺ Cells Proliferating in the Spleens: An Indication for Long-Lived Plasma Cell Activities and Potential Therapeutic Target.

I. Kim, N.-N. Chai, A. Klein, S. Jordan, G. Wu.
Recapitulating Peripheral T Cell Development in Neonatal Mice to Induce Transplant Tolerance.

R. Bascom, K. Tao, L. West.
Receptor Tyrosine Kinase Mer Mediates Expansion of MDSCs Critical for Transplantation Tolerance.

L. Zhang,¹ M. DeBerge,² X. Zhang,³ J. Wang,³ Z. Zhang,³ E. Thorp,² X. Luo.^1,2,3
Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.

D. Keith, G. Vranic, A. Nishio Lucar.
Recipient Outcomes in U.S. Cases of Post-Donation Living Donor Malignancy.

A. Wilk,¹ S. Taranto,¹ M. Nalesnik.³
Reciprocal Effects of HDAC1 and HDAC2 Deletion on Renal Cold Ischemia Survival and Nuclear Co-Repressor Complex Expression.

D. Aufhauser Jr,¹ D. Murken,¹ Z. Wang,¹ A. Samanta,² G. Ge,¹ T. Bhatti,³ W. Hancock,^2,3 M. Levine.¹
Reciprocity for Compatible Pair Participation in Kidney Paired Donation.

J. Gill,¹ M.-C. Fortin,² C. Rose,¹ E. Cole,³ K. Tinckam,³ J. Gill.¹
Recombinant TSGL-Ig Protects Liver Endothelial Cells Against Prolonged Cold Preservation Injury in Mouse Liver Transplantation.

C. Zhang,^1,2 H. Ji,¹ Y. Liu,^1,2 Y. Zhang,^1,2 X.-D. Shen,¹ F. Gao,¹ R. Busuttil, G. Shaw, J. Kupiec-Weglinski.
Recovery of eGFR in Both Donors and Recipients After Living Donor Kidney Transplantation.

J. Verbesey, A. Gilbert, A. Li, M. Reissmann, N. Foreman, M. Grafals, B. Javaid, P. Abrams, S. Ghasemian, M. Cooper.
Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR® Gel.

P. Vaitla, D. Daswatta, A. Guasch.
Reduced CMV Infection Using Single Low-Dose of Rabbit Anti-Thymocyte Globulin in Kidney Transplanted Recipients.

M. Paula, C. Felipe, M. Cristelli, P. Orlandi, L. Viana, G. Basso, P. Carvalho, C. Montenegro, A. Lima, I. Pietrobom, H. Tedesco-Silva, J. Medina-Pestana.
Reduced Incidence and Level of De Novo Donor-Specific Antibodies in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results from BENEFIT.

R. Bray,¹ H. Gebel,¹ R. Townsend,² M. Polinsky,² L. Yang,² U. Meier-Kriesche,² C. Larsen.¹
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus: A Cost-Effectiveness Analyses.

H. Tedesco-Silva, C. Felipe, A. Brigido, M. Cristelli, M. Paula, A. Bessa, P. Ruppel, J. Medina-Pestana.
Reduced Incidence of Rejection in AB0-incompatible Kidney Transplantation – Five Year Follow-Up in a Single Center.

A. Weidemann, F. Karpf, T. Dienemann, K. Birkner, J. Jacobi, K.-U. Eckardt.
Reduced-Dose Cidofovir (CID) and CMV-Hyperimmune Globulin (CMVIg) for Ganciclovir-Resistant Cytomegalovirus: Effective and Kidney Friendly.

S. Patel, S. Kuten, J. Snyder, R. Knight, A. Gaber.
Reducing Non-Anastomotic Biliary Strictures After Donation After Circulatory Death Liver Transplantation, a Matter of Time?

N. Gilbo, I. Jochmans, M. Sainz, J. Pirenne, D. Monbaliu.
Refill-Based Immunosuppression Non-Adherence Is Associated with Increased Death Censored Graft Loss.

K. Wen, S. Gourishankar, S. Shojai, A. Wong, M. Bae, D. Grynoch, P. Halloran.
Regression of Asymptomatic Cardiomyopathy and Clinical Outcome of Renal Transplant Recipients: Long-Term Extension of Two Randomized Controlled Trials.

E. Paoletti, D. Bellino, L. Marsano, R. Russo, F. Masarino, G. Garibotto.
Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

M. Ezzelarab,¹ H. Zhang,¹ L. Lu,¹ H. Guo,¹ A. Zahorchak,¹ R. Wiseman,² M. Nalesnik,³ J. Bhama,¹ D. Cooper,¹ A. Thomson.^1,4
Relationship Between Changes in Brain Natriuretic Peptide Levels and Cardiac Allograft Rejection Early After Heart Transplantation.

J. Dann,¹ K. Deininger,¹ D. Reinhold,¹ R. Page II,¹ A. Ambardekar,¹ J. Lindenfeld,² C. Aquilante.¹
Relationship Between Clinical Events and Everolimus Exposure at 12 Months in De Novo Renal Transplant Recipients.

F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
Relationship Between Dialisys Duration and Prevalence of Cardiovascular Diseases in Kidney Transplantation Recipients.

K. Unagami,¹ M. Okumi,² T. Hirai,² Y. Okabe,³ K. Masutani,⁴ T. Shimizu,² K. Omoto,² M. Inui,² H. Ishida,² T. Kitazono,⁴ K. Nitta,¹ K. Tanabe,² The Japan Academic Consortium of Kidney Transplantation (JACK).
Relationship Between Mean Fluorescence Intensity and C1q/C3d-Fixing Capacities of Anti-HLA Antibodies.

G. Claisse,¹ L. Absi,² E. Alamartine,¹ N. Maillard,¹ C. Mariat.¹
Relative Distribution of Livers from HCV+ Donors in the U.S.

J. Salazar,¹ J. Roberts,¹ N. Mehta,¹ M. Volk,² J. Lai.¹
Removing Geographic and Financial Barriers for Directed Living Kidney Donations: Lessons from Kidney Paired Donation.

M. Aeder,¹ R. Leishman,² D. Stewart.²
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.

E. Tantisattamo,¹ A. Chokechanachaisakul,² S. Pitukweerakul,³ P. Ratanasrimetha,⁴ A. Shetty,² O. Traitanon,⁵ L. Gallon.²
Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.

F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
Renal Efficiency: A New Metric for Evaluating Kidneys in Living Donors.

A. Diez, K. Rima, J. Von Visger, U. Nori, T. Pesavento, A. Rajab, M. Henry, R. Pelletier.
Renal Fibroblast Activation and Survival by Anti-MHC Class I Antibody: The Role of mTOR Signaling Pathway.

J. Chen, A. Zmijewska, R. Mannon.
Renal Function Decline Is Higher in the First Year After Liver Transplantation: Final Results from the Italian Observational Study SURF.

A. Giacomoni,¹ M. Cescon,² G. Magini,³ F. Picciotto,⁴ U. Cillo,⁵ M. Senzolo,⁵ G. Vennarecci,⁶ P. De Simone.⁷
Renal Graft Survival According to Banff 2013 Diagnostic Categories in Indication Biopsies.

D. Redondo-Pachón,¹ C. Arias-Cabrales,¹ M. Pérez-Sáez,¹ J. Gimeno,² I. Sánchez-Güerri,² S. Bermejo,¹ A. Sierra,¹ C. Burballa,¹ M. Mir,¹ M. Crespo,¹ J. Pascual.¹
Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients.

C. Legendre,¹ J. Campistol,² T. Feldkamp,³ J. Wang,⁴ G. Remuzzi,⁵ L. Weekers,⁶ N. Sheerin.⁷
Renal Outcomes of Pediatric Kidney Transplant Recipients Following a Previous Solid Organ Transplantation.

G. Hamdani,¹ B. Zhang,² J. Goebel,³ E. Nehus.¹
Renal Risk Index and Acute Kidney Injury in Liver Transplant Patients.

J. Neal, Y. Sun, J. Erley, J. Shen, C. Sonnenday, P. Sharma, J. Park.
Renal Transplant in Obese Recipients: Consideration of Donor and Recipient Factors Can Improve Outcomes.

P. Stahler, J. Mezrich, G. Leverson, D. Kaufman, H. Sollinger.
Renal Vein Thrombosis Incidence in 3976 Consecutive Kidney Transplants: Retrospective Analyses Focusing on Intraoperative Risk Factors.

H. Marinho Neto, B. Leslie, J. Neves Neto, J. Offerni, A. Pessoa, M. Almeida, M. Nogueira, S. Ximenes, W. Aguiar, H. Tedesco, J. Medina Pestana.
Replacing Cold Storage with Normothermic Ex Vivo Kidney Perfusion Improves Function of Grafts Retrieved After Circulatory Death (DCD).

J. Kaths,^1,2 Y.-M. Chun,¹ D. Cen,¹ J. Echeverri,¹ I. Linares,¹ P. Yip,³ R. John,³ D. Bagli,⁴ I. Mucsi,⁵ A. Ghanekar,¹ D. Grant,¹ L. Robinson,² M. Selzner.¹
Replicative Senescence and Arteriosclerosis After Kidney Transplantation.

K. De Vusser,¹ D. Martens,² E. Lerut,³ D. Kuypers,¹ T. Nawrot,² M. Naesens.¹
Resolution of Donor Non-Alcoholic Fatty Liver Disease Following Liver Transplantation.

A. Posner,¹ W. Twaddell,² S. Hanish,² D. Bruno,² W. Hutson,² L. Hebert,² R. Barth,² J. LaMattina.²
Resolution of Undefined Etiology of Respiratory Infections in Lung Transplant Patients with Unbiased Metagenomic Sequencing.

N. Mueller,¹ D. Lewandowska,² B. Ruehe,² P. Schreiber,¹ O. Zagordi,² F. Geissberger,² M. Schuurmans,³ M. Greiner,¹ A. Zbinden,² J. Boeni,² C. Benden,³ A. Trkola,² M. Huber.²
Resource Utilization and Cost Analysis of Early Hospital Readmissions Following Kidney Transplantation.

M. Au, O. Famure, Y. Li, J. Kim.
Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.

J. Seal, H. Bohorquez, N. Battula, E. Ahmed, D. Bruce, I. Carmody, R. Trevor, G. Tyson, S. Joshi, N. Bzowej, G. Therapondas, N. Girgrah, A. Cohen, G. Loss.
Results of a Biopsy Based, Early Intervention Treatment Protocols for BK Viraemia and BK Virus Associated Nephropathy.

S. Jones,¹ S. Waller,¹ K. Lai,^2,3 A. Hibbard,¹ P. Trevillian,¹ M. Heer.¹
Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in De Novo Living Donor Kidney Transplant Recipients.

A. Skaro,¹ A. LeFever,² J. Mathew,¹ L. Gallon,¹ J. Hie,¹ C. Hansen,² D. Stare,¹ G. Johnson,³ J. Leventhal.¹
Results of Biopsies in Pancreas and Kidney-Pancreas Patients with Graft Dysfunction.

P. Uva, L. Leon, E. Minue, I. Cabrera, A. Giunippero, M. Norese, M. Toniolo, E. Chuluyan, D. Casadei.
Resveratrol Attenuates Liver IRI by Regulating Macrophage Activation Through SIRT1/p19/p53 Pathway.

K. Nakamura,¹ M. Zhang,² B. Ke,¹ S. Kageyama,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
Resveratrol Effectively Suppress Th17 Associated Allo-Immune Responses by the Modulation of AMPK/mTOR Pathway.

B. Chung, K. Doh, J.-W. Min, K. Kim, B.-M. Kim, M.-L. Cho, C. Yang.
Retroperitoneal versus Intraperitoneal Hand Assisted Laparoscopic Donor Nephrectomy: A Case Matched Study.

Z. Ahmed, M. Sait, R. Tamburrini, R. Uwechue, P. Chandak, N. Kessaris, N. Mamode.
Return on Investment for Financial Assistance for Living Kidney Donors in the United States.

A. Mathur,¹ J. Xing,² D. Dickinson,² P. Warren,³ K. Gifford,³ B. Hong,⁴ A. Ojo,⁵ R. Merion.^2,5
Reversibility of Acute Kidney Rejection According to the Banff 2013 Classification: A Retrospective Cohort Study.

A. Poulin,¹ M. Dorais,² L. Sénécal,³ S. Colette,³ H. Cardinal.¹
Review of Aborted Hepatectomy of Liver Transplantation in a Single Center Study.

J. Lee, G. Choi, W. Cho, J.-W. Joh, S.-K. Lee, S.-J. Kim, C. Kwon, J. Park, J. Kim.
Review of Organ Utilization from Increased Infectious Risk Donors.

A. L'Huillier,¹ A. Humar,² C. Payne,³ D. Kumar.²
Risk Factors for Clinical Urinary Tract Infections in Kidney Transplant Recipients with Asymptomatic Bacteriuria.

S. Medani, M. Dorais, A. Tavares-Brum, H. Mawad, A. Duclos, C. Lemieux, A. Barama, H. Cardinal.
Risk Factors for Early Readmission After Total Pancreatectomy with Islet Auto Transplantation.

R. Shahbazov,¹ N. Bashoo,² G. Yoshimatsu,² G. Saracino,² F. Azari,¹ N. Onaca,² P. Kim,² M. Levy.³
Risk Factors for Early vs. Late Onset Clostridium difficile Infection(CDI) in Solid Organ Transplant Recipients (SOTR).

Y. Natori, M. Shiotsuka, L. Oen, E. Renner, L. Singer, H. Ross, D. Kumar, C. Rotstein, A. Humar, S. Husain.
Risk Factors for Hospitalization Among Waitlisted End Stage Renal Disease Patients.

K. Newman,^1,2 A. Adams,² S. Pastan,² R. Lynch,² R. Zhang,¹ R. Patzer.^1,2
Risk Factors for Short and Long Term Mortality in High MELD Recipients.

A. Bertacco,^1,2 M. Rodriguez-Davalos,¹ M. Schilsky,³ P. Yoo,¹ S. Kulkarni,¹ B. Fortune,³ A. Liapakis,³ S. Emre,¹ D. Mulligan.¹
Risk Factors for Single and Recurrent Symptomatic Urinary Tract Infections within the First Year After Kidney Transplantation.

K. Bourgi, W. Choi, A. Nakhle, Z. Abdel-Rahman, O. Abreu-Lanfranco, M. Ramesh, A. Patel, R. Del Busto, G. Alangaden.
Risk Factors for the Development of CMV Viremia in a Cohort of Morbidly Obese Kidney Transplant Recipients Under Low Dose Valganciclovir Prophylaxis.

J. Thielke,¹ N. Jasiak,¹ N. Hilal,¹ S. Salah,¹ E. Benedetti,² P. West-Thielke.²
Risk of Acute Rejection Among ABO Incompatible Living Donor Kidney Recipients.

P. MacLennan, V. Kumar, R. Reed, D. Mompoint-Williams, K. Stegner, J. Locke.
Risk of ESRD in Potential HIV+ Live Kidney Donors.

A. Muzaale,¹ L. Kucirka,¹ A. Massie,¹ C. Durand,¹ J. Locke,² G. Lucas,¹ D. Segev.¹
Risk of Peritoneal Dialysis Catheter-Associated Peritonitis Following Kidney Transplant.

A. Rizzi,¹ S. Ruitta,¹ J. Peterson,¹ G. Gagin,¹ D. Fritze,¹ R. Sung,¹ Y. Lu,² K. Woodside.¹
Risk Prediction of End-Stage Renal Disease in Living Kidney Donors.

A. Massie, E. Chow, D. Segev.
Risk Stratification for Optimized Utilization of Deceased Donor Kidneys with Acute Kidney Injury by KDIGO Criteria.

B. Yu,¹ T. Koo,² J. Lee,³ J. Yang,² J. Ha,⁴ C. Ahn,¹ Y. Kim,¹ H. Lee.¹
Rituximab Induction in Cardiac Transplantation Is Associated with Accelerated Coronary Artery Vasculopathy: CTOT11.

A. Chandraker, J. Kobashigawa, J. Stehlik, M. Givertz, R. Pierson, S. Pinney, M. Joren, S. Nissen, I. Guleria, Y. Morrison, B. Armstrong, N. Bridges, M. Sayegh, R. Starling.
RNAseq Transcriptome Analysis of Bone Marrow CD138⁺ Plasma Cell Responses to Carfilzomib Monotherapy Desensitization.

J. Driscoll, B. Aronow, S. Tremblay, R. Alloway, E. Woodle.
Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival – 48 Months of Follow-up.

I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.
Robotic-Assisted Laparoscopic Donor Nephrectomy with Transvaginal Extraction of the Kidney.

C. Champy,¹ L. Salomon,¹ I. Cholley,¹ A. Hoznek,¹ R. Yiou,¹ D. Vordos,¹ P. Grimbert,² P. Lang,² A. De La Taille.¹
Role of Cardiac Evaluation and Management in Kidney and Liver Transplant Candidates.

W. Bannister, C. Wu, M. Schnitzler, A. Bonagura, B. Laihinen, F. Irwin.
Role of Donor Hemodynamic Trajectory in Determining Graft Survival in Liver Transplantation from Donation After Circulatory Death Donors.

D. Firl, K. Hashimoto, C. O'Rourke, J. Fung, B. Eghtesad.
Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients.

B. Chopra, K. Sureshkumar.
Role of Natural Killer Cells in Kidney Transplant Outcome.

E. Carta,¹ R. Littera,² M. Murgia,¹ M. Michittu,¹ B. Onano,¹ G. Piredda,¹ D. Argiolas.¹
Role of NRP1 in CD4+ T Cell Allo-Activation.

E. Lee, H. Kim, G. Demirci.
Role of Preformed IgM Donor Human Leucocyte Antigen (HLA) Specific Antibodies in HLA Incompatible Renal Transplantation.

A. Andreou, A. Babu, T. Barber, R. Higgins, D. Briggs, D. Mitchell, N. Khovanova, T. Shaikhina, S. Daga.
Role of Regulatory T Cells in Induction of Tolerance in Mouse Vascularized Osteomyocutaneous Allotransplantation Under Combined Costimulation Blockade.

M. Anggelia,¹ H.-Y. Cheng,¹ Y.-L. Wang,¹ W.-Y. Chuang,¹ C.-H. Lin,¹ G. Brandacher,² F.-C. Wei,¹ C.-H. Lin.¹
Role of TGF-β in Ischemia and Reperfusion Injury Induced Renal Fibrosis in Human Proximal Tubular Epithelial Cells.

R. Kapoor, N. Sheerin, J. Kirby.
Rurality Status Does Not Affect Kidney Transplant (KTP) Rates Among Veterans Compared to Medicare, Medicaid, and Private Insurance (PrivIns) Beneficiaries.

R. Kalil,^1,2 C. Franciscus,² A. O'Shea.^1,2

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z